Document is current

Article History

Received: 30 April 2020

Revised: 29 July 2020

Accepted: 7 August 2020

First Online: 28 August 2020

Compliance with ethical standards

:

: AN: Honoraria-DCI, Consulting or Advisory Role-Karyopharm Therapeutics, Tolero Pharmaceuticals, Speakers’ Bureau-Novartis, Incyte, Research Funding-Jazz Pharmaceuticals. RAW: Alexion: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Novartis: Honoraria, Research Funding. MG: Celgene: Honoraria, Research Funding; Alexion: Honoraria, Research Funding; Novartis: Honoraria, Research Funding. M-MK: Consultant—Seattle Genetics (brentuximab vedotin), Honoraria—Novartis, Scientific Advisory Board—Janssen, Shire Hoffman-La Roche, Sanofi Genzyme, Celgene. BL: Medical Advisory Boards and Speaker Bureau—Celgene, Pfizer, Novartis, AMGEN, Astellas, Otsuka, Jazz, Abbvie. MS: Advisory Boards—Jazz, Pfizer, Novartis, Astellas, Celgene. HAL: Advisory Boards, Honoraria, Research Funding—Abbvie, Alexion, Celgene, Novartis, Advisory Boards, Honoraria—Otsuka. ESt-H: Advisory Boards—BMS, Amgen, Celgene, Teva, Novartis, Speaker Honoratrium—BMS, Sanofi, Novartis. NF: Research Support—Boehringer Ingelheim, Roche, Pfizer, Merck, Honoraria—Roche, Novartis, Bristol Myers Squibb, Celgene, Pfizer, Scientific Advisory Board—Novartis, Pfizer, Lundbeck, Celgene, Janssen, Sanofi, Alexion, Roche, Ipsen, Takeda, Merck, Amgen, Bristol Myers Squibb, Astra Zeneca. AS: Advisory Boards: Amgen, Janssen, Abbvie, Celgene, Sponsored talks—Janssen. KWLY: Research Funding—Astex, Hoffman-La Roche, MedImmune, Merck, Millenium, Roche/Genentech, Honoraria—Novartis, Pfizer, Board of Directors or Advisory Committees: Astellas, Celgene, Novartis, Pfizer, Takeda. JS: Advisory Boards—Celgene, Novartis, Pfizer, Astellas, Abbvie, Amgen, speaking fees—Teva, Celgene, travel support—Pfizer. TJN: Ad boards and Sponsored talks—Celgene, Alexion, Novartis, Ad boards—Paladin Labs, Otsuka. RD: Celgene: Honoraria, Research Funding; Novartis: Honoraria, Research Funding. VB: Industry Research Funding—Gilead, Janssen, Roche, Ad boards—Abbvie, Astra Zeneca, Janssen, Gilead, Roche, Sponsored talk—CAPhO Abbvie, Academic Research Support—CIHR, LLSC, Research Manitoba and CancerCare Manitoba Foundation, Licensing Fees—BIOGEN and The Dana-Farber Cancer Institute. RB: Research Funding support and Honoraria for Advisory Board panels—Celgene, Research Funding support—Otsuka, Takeda. The other authors declare that they have no conflict of interest.